Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects With GNE Myopathy
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2024
Price :
$35
*
At a glance
- Drugs N acetyl D mannosamine (Primary)
- Indications Nonaka distal myopathy
- Focus Therapeutic Use
- Acronyms MAGiNE
- 07 Jun 2023 Status changed from recruiting to active, no longer recruiting.
- 20 Apr 2022 Status changed from not yet recruiting to recruiting.
- 01 Mar 2022 Planned End Date changed from 15 Jun 2024 to 15 Jul 2024.